The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to Avoid
October 12, 2017 at 14:34 PM EDT
An analyst at Raymond James warns that while gene therapy stocks have taken off like a rocket, not all gene therapies are equal. The firm launched coverage on 5 stocks, declaring that "the gene therapy era as arrived."
